Published in Blood Weekly, October 6th, 1997
The findings, published in the September 1997 issue of Nature Biotechnology, reported that researchers have significantly improved the safety profile of the lentiviral vector by eliminating the five genes associated with virulence, without reducing the efficiency of gene delivery. Among the advantages of lentiviral vectors are their ability to efficiently and stably infect non-dividing cells, such as those comprising...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.